lung cancer
Conditions
Interventions
PVB group:25-30ug sufentanil during operation +T2 PVB
control group:Perioperative conventional sufentanil dosage
Sponsors
Chongqing Cancer Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Agree to join the study and obtain informed consent; 2) Aged between 30-75 years; 3) BMI < 30 4) American Society of Anesthesiologists (ASA) Classification I-III; 5) Diagnosis of lung cancer in hospital, receiving thoracoscopic radical resection of lung cancer.
Exclusion criteria
Exclusion criteria: 1) T2 paravertebral block can not be performed for various reasons; 2) Patients with coagulation dysfunction or receiving anticoagulation therapy; 3) Persons with a history of upper limb nerve injury or phrenic nerve injury; 4) Compound injury; 5) Preoperative Pulse Oxygen Saturation(SPO2)180 mmHg or diastolic blood pressure>110 mmHg) 7) Uncontrolled coronary heart disease, valvular heart disease and arrhythmia before operation; 8) Any reason that causes nerve block impossible to be performed (e.g. local infection at puncture site, swelling, unable to change position, etc.); 9) Fail to communicate or cooperate (mental retardation, Alzheimer, Parkinson, etc.); 10) Be allergic to ropivacaine or has other contraindications for nerve block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NLR;Cell index function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dosage of remedial analgesics;QoR-40; | — |
Countries
China
Contacts
Public ContactBin Yang
Department of Anesthesiology, Chongqing Cancer Hospital
Outcome results
None listed